PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 18 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Saponins demonstrated statistically significant neuroprotective and antioxidant activity in an in vitro rat brain synaptosome model [PMID:30470136, PMID:37512564]
A purified saponins' mixture (PSM) induced a statistically significant decrease in the viability and proliferation of Graffi tumour cells in vitro and affected tumour growth and survival in vivo in hamsters [PMID:33137432]
Methanol extracts, purified saponin mixtures, and isolated saponins were studied for antiviral effects on human coronavirus replication in vitro [PMID:38003714]
Evidence summary
PubMed sources
- 1.PMID: 38003714 (2023) — Effect of a Total Extract and Saponins from Astragalus glycyphyllos L. on Human Coronavirus Replication In Vitro. · International journal of molecular sciences
- 2.PMID: 37512564 (2023) — Cycloartane Saponins from Astragalus glycyphyllos and Their In Vitro Neuroprotective, Antioxidant, and hMAO-B-Inhibiting Effects. · Metabolites
- 3.PMID: 39856916 (2025) — Nutritional, Chemical, Antioxidant and Antibacterial Screening of Astragalus cicer L. and Astragalus glycyphyllos L. Different Morphological Parts. · Foods (Basel, Switzerland)
- 4.PMID: 26496493 (2015) — Phylogeny of Symbiotic Genes and the Symbiotic Properties of Rhizobia Specific to Astragalus glycyphyllos L. · PloS one
- 5.PMID: 30470136